Comparative Antidote Efficacy
Comparative Antidote Efficacy is a metric that quantifies the relative effectiveness of fomepizole versus alternative antidotes in mitigating toxicological outcomes within controlled clinical or experimental settings.
7
Publications
577
Citations
35
Authors
16
Institutions
Publications per year
2017–2026
0
Parents
7
1–5 of 7
35
1
h-index
1
h-index
University of California, Los Angeles, United States
1 publications · 336 citations
1
h-index
1
h-index
National Institute for Public Health and the Environment, Netherlands
1 publications · 20 citations
1
h-index
1–5 of 35
16
KU Leuven
Leuven, Belgium
1 h-index
3 publications
63 citations

Wroclaw Medical University
Wroclaw, Poland
1 h-index
6 publications
126 citations
University Medical Center Utrecht
Utrecht, The Netherlands
1 h-index
1 publications
78 citations
National Institute of Public Health
Bissau, Guinea-Bissau
1 h-index
4 publications
80 citations
Ospedale Humanitas Gradenigo
Turin, Italy
1 h-index
1 publications
20 citations

University of British Columbia
Vancouver, Canada
1 h-index
3 publications
234 citations
Heliodor Swiecicki Clinical Hospital
Poznań, Poland
1 h-index
1 publications
21 citations
Poznan University of Medical Sciences
Poznan, Poland
1 h-index
1 publications
21 citations
1–8 of 16
1 publications · 23 citations
1
h-index
Repository · 1 publications · 78 citations
1
h-index
1 publications · 20 citations
1
h-index
1 publications · 336 citations
1
h-index
1 publications · 21 citations
1
h-index
1–5